Abstract

In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared. Virtual visits and telemonitoring strategies became routine. Evidence is accumulating regarding the safety and efficacy of virtual visits to replace in-person visits. A structured approach to virtual encounters is recommended. Telemonitoring includes patient reported remote vital sign monitoring, information from wearable devices, cardiac implantable electronic devices and invasive remote hemodynamic monitoring. The intensity of the monitoring should match the risk profile of the patient. Attention to cultural and educational barriers is important to prevent disparities in telehealth implementation.

Highlights

  • Heart failure (HF) is a chronic disease characterized by high mortality, often associated with multiple comorbidities that require a multidisciplinary treatment approach [1,2,3,4,5]

  • Telemedicine and telemonitoring are an integral part of those programs, and their application increased exponentially in 2020–2021 during the COVID-19 pandemic [12, 13]

  • This review focuses on telemedicine’s current role in HF management and provides a practical framework for its application

Read more

Summary

Introduction

Heart failure (HF) is a chronic disease characterized by high mortality, often associated with multiple comorbidities that require a multidisciplinary treatment approach [1,2,3,4,5]. 6 million adults live with HF in the United States. Assuring access of those patients to specialized care, potentially life-saving therapies, and overcoming psychosocial, economic, and geographical barriers is a significant challenge [6,7,8,9,10]. Health care systems have developed disease management programs organized as spoke and hub models to overcome these limitations [11]. Telemedicine and telemonitoring are an integral part of those programs, and their application increased exponentially in 2020–2021 during the COVID-19 pandemic [12, 13]. This review focuses on telemedicine’s current role in HF management and provides a practical framework for its application

Telemedicine and telemonitoring in heart failure
Telemonitoring interventions
Wearables
Cardiac implantable electronic devices
Remote hemodynamic monitoring
Recent telemedicine and telemonitoring trials
Lessons from the COVID-19 pandemic
Design
Telemedicine in the heart failure clinic
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call